期刊文献+

Expression of Survivin Gene and Its Relationship with Clinical Multidrug Resistance in Osteosarcoma

Survivin基因在骨肉瘤中的表达及其与临床耐药的相关性研究(英文)
暂未订购
导出
摘要 Objective: To study the expression of survivin and its relationship with clinical multidrug resistance in osteosarcoma. Methods: By using immunohistochemistry (S-P) method, the expression of Survivin in osteosarcoma, osteochondroma and normal osseous tissue, and the expression of P-glycoprotein in osteosarcoma was detected. Results: Survivin positive expression rate was 65.71% in osteosarcoma, but no expression of Survivin was detectable in osteochondroma and normal osseous tissue. The positive expression rate of Survivin was significantly associated with Enneking clinical stages and histological typing (WHO), but no relationship was found among Survivin expression and age, sex and tumor location. The positive expression rate of P-glycoprotein was 45.71%. There was a significant correlation between Survivin and p-glycoprotein. Conclusion: Survivin overexpression was significantly associated with clinical multidrug resistance in osteosarcoma. It could be a potential target for treatment of osteosarcoma.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2005年第3期164-166,189,共4页 中德临床肿瘤学杂志(英文版)
基金 The project was supported by the reasearch of Education Institution in Jiangxi (No. E040506).
关键词 OSTEOSARCOMA SURVIVIN IMMUNOHISTOCHEMISTRY 骨肉瘤 药物治疗 表面基因 基因表达
  • 相关文献

参考文献11

  • 1Ham S J, Schraffordt Koops H, vander Graaf WT, et al. Historical, current and future aspects of osteosarcoma treatment. EurJ Surg Oncol, 1998, 24: 584.
  • 2Adiada C, Crotty PL, Mcgrath J, et al. Developmentally regulated expression of thenovel cancer anti-apoptosis gene Survivin in human and mouse differentiation. Am J Pathol,1998, 152: 43-49.
  • 3Schajowicz F, Sissons HA, Sobin H. The World Health Organization's histologicalclassification of bone tumor.A commentary on the second edition. Cancer,1995,75:1208-1213.
  • 4Kawasaki H, Toyoda M, Shinohara H, et al. Expression of Survivin correlates withapoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis.Cancer,2001, 91: 2026-2032.
  • 5Rohayem J, Dietelkoetter P, Weigle B, et al. Antibody response to thetumor-associated inhibitor of apoptosis protein Survivin in cancer patients. Cancer Res,2000, 60:1815-1817.
  • 6Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, et al. Prognostic value of nuclearSurvivin expression in oesophagel squamous cell carcinoma. Br J Cancer, 2003, 88: 115-119.
  • 7Kajiwara Y, Yamasaki F, Hama S, et al. Expression of Survivin in astrocytic tumors.Cancer, 2003, 97:1077-1083.
  • 8Wang BL, Xiao ZY, Chen XP, et al. Studies on the relationship between multidurgresistance 1 gene and pancreatic cancer. Chinese-German J Clin Oncol, 2004, 3: 15-19.
  • 9Labialle S, Gayet L, Marthinet E, et al. Transcriptional regulators of the humanmultidrug resistance 1 gene: recent views. Biochem Pharmacol, 2002, 64: 938-943.
  • 10Hegewisch-Becker S, Hossfeld DK. The MDR phenotype in hematologic malignancies:prognostic relevance and future perspectives. Ann Hematol, 1996, 72: 105-117.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部